,
Karin Verzijden
How do you communicate the main characteristics of your product to the public? First of all by its name of course – fair enough. At second glance, the list of ingredients comes…
,
Erik Vollebregt
If you are active in the medical software field in the Netherlands you may probably be aware already that the the Dutch healthcare Inspectorate IGZ has announced that it will rigorously enforce…
,
Erik Vollebregt
Compromising is time consuming business, that’s for sure. And sometimes it’s not easy to reach compromises. Apparently the ENVI Committee members were not able to reach compromises timely, because the postponed vote…
,
Karin Verzijden
Your company wants to provide bullet proof information on the food products it offers for sale in view of the upcoming changes in food legislation? This post may be helpful to you,…
,
Erik Vollebregt
Everybody (I would hope so for the sake of cultural standards) will be familiar with the famous Monty Python sketch about the two bored pilots that decide to make things interesting by…
,
Erik Vollebregt
If you are active in the medical software field in the Netherlands you may probably be aware already that the the Dutch healthcare Inspectorate IGZ has announced that it will rigorously enforce…
,
Karin Verzijden
If you like to add a new ingredient to – for example – a beverage or want to start selling ‘superberries’ or an exotic seed from Asia in the EU, you should…
,
Erik Vollebregt
It’s time for a celebration! Why? Did the ENVI committee magically produce a proposal that makes a lot of sense, and ahead of time? Unfortunately not – we still have to wait…
,
Erik Vollebregt
I have just written annotations to the Abbvie and Intermune cases under EU pharmaceutical law for the next issue of the Dutch legal journal Jurisprudentie Geneesmiddelenrecht (in Dutch, sorry) but of course that…